JUHE:XETRA:XETRA-JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity UCITS ETF - EUR Hedged (acc) (EUR)

ETF | Others |

Last Closing

USD 43.62

Change

+0.04 (+0.09)%

Market Cap

N/A

Volume

1.64K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.44 (-0.85%)

USD 484.40B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.14 (-0.85%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.23 (-0.83%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.23 (-0.80%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.34 (-1.36%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-1.28 (-0.89%)

USD 98.29B
JARI:XETRA Amundi Index Solutions - Amund..

-0.34 (-0.73%)

USD 98.25B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.44 (-0.86%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.60 (-0.11%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.11 (-0.48%)

USD 79.79B

ETFs Containing JUHE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.87% 76% C+ 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.87% 75% C 74% C
Trailing 12 Months  
Capital Gain 29.94% 86% B+ 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.94% 86% B+ 84% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.81% 67% D+ 65% D
Dividend Return 7.81% 66% D+ 62% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.87% 55% F 63% D
Risk Adjusted Return 65.83% 81% B- 82% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike